Gara Jalqabaatti › Neuroblastoma › Alabama
Qorannoo klinikaalii Neuroblastoma Alabama keessatti
Qorannoo 8 Neuroblastoma f Alabama keessatti hirmaatuu jiru.
Magaalota Alabama keessatti
Takkalaa qorannoo (Ingiliffa)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Children's Hospital of Alabama, Birmingham
- USA Health Strada Patient Care Center, Mobile
Namoota walitti qabaa jiraSadarkaa 3
Hanga umuriin 30 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06172296Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- University of Alabama/Children's of Alabama, Birmingham
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 22 · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT02559778Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- University of Alabama/Children's of Alabama, Birmingham
Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 26 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06465199Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- University of Alabama/Children's of Alabama, Birmingham
Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 30 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06541262Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Children's Hospital of Alabama, Birmingham
Namoota walitti qabaa jiraSadarkaa 3
365 Days – 30 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital of Alabama, Birmingham
Namoota walitti qabaa jiraSadarkaa 1/2
12 Months – 30 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04851119Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- University of Alabama/Children's of Alabama, Birmingham
Namoota walitti qabaa jiraSadarkaa 2
12 Months – 21 Years · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT05489887A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's Hospital of Alabama/UAB, Birmingham
Namoota walitti qabaa jiraSadarkaa 2
18 Months – 40 Years · Saalaa hunda · Haaromfame 12-Hag-2025 · NCT05135975Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.